Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction
NCT ID: NCT04126252
Last Updated: 2019-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
116 participants
INTERVENTIONAL
2018-08-29
2019-09-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study
NCT04179747
Satisfaction, Confidence and Naturalness in Men With Psychogenic Erectile Dysfunction (ED)
NCT01153204
Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
NCT00422734
A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China
NCT01352507
Tadalafil for Erectile Dysfunction in Patients With Cirrhosis
NCT03566914
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
This arm received pharmacotherapy for erectile dysfunction.
Sildenafil Citrate 50Mg Tab
The Group A received sildenafil citrate 50 mg on demand for a period of max 3 months.
Group B
This arm received cognitive behavior psychotherapy for erectile dysfunction.
Cognitive Behavioral Psychotherapy
The Group B received cognitive behavior psychotherapy for a period of max 3 months.
Group C
This arm received combined treatment approach.
Combined or Integrated Therapy
The Group C received the combined therapeutic approach for a period of max 3 months.
Group D
This arm acted as a control group and received placebo or no intervention.
Placebo
The Group D received no treatment or placebo for a period of max 3 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sildenafil Citrate 50Mg Tab
The Group A received sildenafil citrate 50 mg on demand for a period of max 3 months.
Cognitive Behavioral Psychotherapy
The Group B received cognitive behavior psychotherapy for a period of max 3 months.
Combined or Integrated Therapy
The Group C received the combined therapeutic approach for a period of max 3 months.
Placebo
The Group D received no treatment or placebo for a period of max 3 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be in the age range of 18 to 40 years
* Must be in a stable heterosexual relationship
* Must not be suffering from any medical or psychiatric illness
Exclusion Criteria
* Men not in a heterosexual relationship
* Men above the age of 40 years
* Men diagnosed with any medical or psychiatric illness
18 Years
40 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Islamic University, Islamabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmad Bilal
Principal Investigator, PhD Research Candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmad Bilal
Role: PRINCIPAL_INVESTIGATOR
International Islamic University, Islamabad, Pakistan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmad Bilal Private Practice
Chak Eighty-seven -Twelve Left, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bilal A, Abbasi NUH. Development of an indigenous manual of cognitive behavior sex therapy for young men. J Family Med Prim Care. 2022 Aug;11(8):4127-4130. doi: 10.4103/jfmpc.jfmpc_1892_21. Epub 2022 Aug 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0925-0586
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.